We found 436 records for "Regulatory / compliance"

Articles

TTIP – bringing benefits to patients or big pharma?

22nd September 2014

 TTIP – bringing benefits to patients or big pharma?Articles

Emma Woodford, EPHA Interim Secretary General, explains the organisation's stance on the Transatlantic Trade and Investment Partnership (TIPP) and the wider implications for health once negotiations close towards the end...

Read more

Real world cost effectiveness: lessons from the MS risk sharing scheme

19th September 2014

 Real world cost effectiveness: lessons from the MS risk sharing schemeArticles

Real world cost effectiveness data is in high demand, but how easy is it to find and assess in practice? Leela Barham investigates the pros and cons through an examination...

Read more

How can UK pay for Sovaldi? Health bonds, says pharma leader

18th September 2014

 How can UK pay for Sovaldi?  Health bonds, says pharma leaderArticles

The problem of highly effective but high priced and 'unaffordable' medicines such as Sovaldi needs to be addressed in the UK - and could be solved by adopting creative solutions.That...

Read more

Clinical trials insight: cardiovascular disease

10th September 2014

 Clinical trials insight: cardiovascular diseaseArticles

In the latest in a series of interviews with INC Research clinical trial specialists, pharmaphorum talks to Sally Osmond, therapeutic business unit head for the company's Cardiovascular & Endocrinology group.What...

Read more

News

Opdivo to be reviewed in Europe for lung cancer

29th September 2014

 Opdivo to be reviewed in Europe for lung cancerNews

Bristol-Myers Squibb has announced that its new immunotherapy treatment nivolumab has been accepted for review by the EMA for non-small cell lung cancer (NSCLC).The EMA has formally accepted the firm's submission, which puts it in pole...

Read more

CHMP gives positive opinion for HIV drug Rezolsta

29th September 2014

 CHMP gives positive opinion for HIV drug Rezolsta  News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Rezolsta (darunavir/cobicistat) in combination with other antiretroviral medicinal products...

Read more

NICE rejects TNF-a drugs for ulcerative colitis

25th September 2014

 NICE rejects TNF-a drugs for ulcerative colitisNews

Three drugs in the TNF-alpha blocker class have been rejected by NICE on cost and clinical effectiveness grounds compared to existing treatments.England's National Institute for Health and Care Excellence (NICE) says in draft guidance...

Read more

Novartis' arthritis drug to take on Stelara

25th September 2014

 Novartis' arthritis drug to take on StelaraNews

New Phase 3 data from Novartis' secukinumab shows the drug is effective in treating psoriatic arthritis (PsA).The company says it will use the new data in its submission to regulators...

Read more

White Papers

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Engage with confidence: Managing online adverse event reporting

18th March 2014

 Engage with confidence: Managing online adverse event reportingWhite Papers

The pharmaceutical industry is waking up to the enormous potential offered by social media and other online data sources for informing better decisions around drug development and commercialization. Here, Siva...

Read more

The Healthcare Meetings Forum 2013

22nd October 2013

 The Healthcare Meetings Forum 2013White Papers

Healthcare meetings are experiencing a time of change, as new compliance regulations, the rise of digital and the flexing needs of healthcare providers force adaptation. This has raised concerns across...

Read more

Audio & Video

Rare Disease Day tweetchat

  To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click here. During the hour-long tweetchat, we covered the following questions:   1) What are...

Read more

Events

Healthcare World Asia 2014

29th September 2014 - 2nd October 2014

Healthcare World Asia 2014

Healthcare World Asia is the regional industry meeting that senior level healthcare operators attend. This event addresses the latest trends, opportunities and challenges in private healthcare investments, hospital operations & healthcare...

Read more

12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum

29th September 2014 - 3rd October 2014

12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum

IQPC’s 12th Cold Chain GDP & Temperature Management Logistics Global Forum – taking place September 29 – October 3, 2014 at the Hynes Convention Center in Boston, MA –...

Read more

Payers' Forum Europe

1st October 2014 - 2nd October 2014

Payers' Forum Europe

This is the event to ensure your product’s access and to ensure its reimbursed and at the best price. Speaking at the event, we have the top payers from NHS,...

Read more

The 2nd Microbiome/Microbiome R&D and Business Collaboration Forum

2nd October 2014 - 3rd October 2014

The 2nd Microbiome/Microbiome R&D and Business Collaboration Forum

Research into the Microbiome is having an impact on our understanding of a whole host of medical conditions. From arthritis to cancer, diabetes to obesity and organ development to metal...

Read more

Press Releases

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

23rd September 2014

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

Forbes blogger Leonard Kish described “patient engagement as the blockbuster drug of the century” namely for its potential impact on improving patient outcomes. Two years on from his article, I asked;...

Read more

PMCPA selects The EarthWorks as communications partner and app developer for new code

28th July 2014

PMCPA selects The EarthWorks as communications partner and app developer for new code

The Prescription Medicines Code of Practice Authority (PMCPA) announced today that it will be working in partnership with The EarthWorks to create a communications programme, including an app to help...

Read more

New WMF article on global healthcare gaps published

29th May 2014

New WMF article on global healthcare gaps published

WMF recently published an article in Pharmaceutical Physician, which looks at the shocking gaps in healthcare that exist across the world and summarises how the organisation is helping to improve...

Read more

Industry and the NHS - can promotion and partnership co-exist … a debate hosted by the PM Society Market Access Interest Group …

11th February 2014

Industry and the NHS - can promotion and partnership co-exist … a debate hosted by the PM Society Market Access Interest Group …

  Chair: Beverly Barr, Vice-Chair and Market Access Lead, PM Society Panel: Di Vegh, NHS Partnership Manager, ABPI:  How to avoid divorce in your NHS partnerships   Felicity Greene, Director of Operations at NHS South...

Read more